Home Health Care News May 8, 2024
A new report claims that home health giant Amedisys Inc. (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) are closing in on a sizable divestment package to help circumvent antitrust concerns from regulators.
UnitedHealth Group and its Optum arm announced a $3.3 billion deal to acquire Baton Rouge, Louisiana-based Amedisys last year, luring the in-home care company away from previous suitor Option Care Health (Nasdaq: OPCH). Since the deal was announced, UnitedHealth Group has faced mounting pressure from individual lawmakers and federal regulators alike.
Specifically, the new report comes from The Capitol Forum, a news organization that covers antitrust, merger control, corporate investigations and related topics.
In that report, The Capitol Forum claims that UnitedHealth Group and Amedisys have a plan...
Today's Sponsors
Today's Sponsor